A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib

被引：33

作者：

Gruber, F. X. ^{[1
]}

Hjorth-Hansen, H.

Mikkola, I.

Stenke, L.

Johansen, T.

机构：

[1] Univ Tromso, Dept Pharmacol, Inst Pharm, Tromso, Norway

[2] St Olavs Hosp, Dept Hematol, Trondheim, Norway

[3] Karolinska Univ Hosp & Inst, Hematol Ctr, Stockholm, Sweden

[4] Univ Tromso, Inst Med Biol, Dept Biochem, Tromso, Norway

来源：

LEUKEMIA | 2006年 / 20卷 / 11期

关键词：

D O I：

10.1038/sj.leu.2404400

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2057 / 2060

页数：5

共 8 条

[1] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].

Gabert, J ;

Beillard, E ;

van der Velden, VHJ ;

Bi, W ;

Grimwade, D ;

Pallisgaard, N ;

Barbany, G ;

Cazzaniga, G ;

Cayuela, JM ;

Cavé, H ;

Pane, F ;

Aerts, JLE ;

De Micheli, D ;

Thirion, X ;

Pradel, V ;

González, M ;

Viehmann, S ;

Malec, M ;

Saglio, G ;

van Dongen, JJM .

LEUKEMIA, 2003, 17 (12) :2318-2357

[2] Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].

Gorre, ME ;

Mohammed, M ;

Ellwood, K ;

Hsu, N ;

Paquette, R ;

Rao, PN ;

Sawyers, CL .

SCIENCE, 2001, 293 (5531) :876-880

[3] Selecting and deselecting imatinib-resistant clones:: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL [J].

Gruber, FXE ;

Lamark, T ;

Ånonli, A ;

Sovershaev, MA ;

Olsen, M ;

Gedde-Dahl, T ;

Hjort-Hansen, H ;

Skogen, B .

LEUKEMIA, 2005, 19 (12) :2159-2165

[4] Molecular and chromosomal mechanisms of resistance to imatinib (ST1571) therapy [J].

Hochhaus, A ;

Kreil, S ;

Corbin, AS ;

La Rosée, P ;

Müller, MC ;

Lahaye, T ;

Hanfstein, B ;

Schoch, C ;

Cross, N ;

Berger, U ;

Gschaidmeier, H ;

Druker, BJ ;

Hehlmann, R .

LEUKEMIA, 2002, 16 (11) :2190-2196

[5]

Martinelli G, 2005, HAEMATOLOGICA, V90, P534

[6] Automated splicing mutation analysis by information theory [J].

Nalla, VK ;

Rogan, PK .

HUMAN MUTATION, 2005, 25 (04) :334-342

[7] Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase [J].

Schindler, T ;

Bornmann, W ;

Pellicena, P ;

Miller, WT ;

Clarkson, B ;

Kuriyan, J .

SCIENCE, 2000, 289 (5486) :1938-1942

[8] Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia [J].

Shah, NP ;

Nicoll, JM ;

Nagar, B ;

Gorre, ME ;

Paquette, RL ;

Kuriyan, J ;

Sawyers, CL .

CANCER CELL, 2002, 2 (02) :117-125

← 1 →